Engineered Tissue Solutions (ETS) specializes in advanced wound care through its innovative bioactive glass technology, specifically the Mirragen® wound matrix. This unique product is designed to facilitate quality tissue formation while minimizing the risk of infection commonly associated with traditional tissue-based products. The bioactive glass fiber matrix offers a versatile and easy-to-use solution for treating challenging wounds, making it a significant advancement in the field of wound care. ETS emphasizes the safety, effectiveness, and efficiency of its products, which are manufactured in the United States, ensuring high-quality standards.

In addition to its flagship product, ETS is committed to empowering healthcare providers and patients through education and support. The company actively participates in workshops and events to disseminate knowledge about bioactive glass technology and its applications in wound management. ETS's mission is to restore patient well-being and enhance their quality of life by providing innovative solutions that address complex wound care challenges. The recognition of ETS as a leading wound care solution provider underscores its dedication to transforming healing practices in the medical community.

United States

Engineered Tissue Solutions (ETS) is an emerging wound care company, re-defining wound care with cutting-edge bioactive glass technology that reduces healing time, minimizes treatment costs and improves patient outcomes.

Our flagship product, MIRRAGEN® Advanced Wound Matrix, is a next-generation intervention for wound healing. Using synthetic, absorbable bioactive glass fiber technology, MIRRAGEN accelerates healing, decreases wound area, reduces costs, and is safe and easy to use.

Engineered Tissue Solutions (ETS)

Company Details